The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

Volume: 19, Issue: 1
Published: Apr 4, 2019
Abstract
In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic factor. The purpose of this retrospective study was to investigate if somatic mutations could represent an additional prognostic value in respect of MRD alone.At baseline, 98 patients were tested for NPM1, FLT3, and...
Paper Details
Title
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
Published Date
Apr 4, 2019
Volume
19
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.